Deciding whether to invest in a good idea is hard. Even when its potential is clearly explained. Trying to make that evaluation without a solid explanation is an exercise in needless frustration. I’ve talked about the role of a compelling executive summary to get an investor’s initial attention and secure their agreement to take a pitch meeting. But what should that investor expect out of the ensuing pitch deck?
- Delta Development Team – Introducing BloodCOMM Premium
- Special Operations Forces Blood Cooler from Delta Development
- UACI startup alumni Reglagene making impressive strides in brain cancer treatment
- Reglagene RGN6024 Cover Story August 2025 Molecular Cancer Therapeutics
- Calls for More Angel Investing
- Takes a Licking and Keeps on Ticking
- Ventura County firefighters make history with in-the-field blood transfusions
- FireRescue1’s “3 Things We’re Watching at FDIC 2025
- Delta Ice 1L debut at New Castle Blood Symposium
- The next evolution in Prehostial Blood Management